Phase 3 Primary Hypercholesterolaemia Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd.582 enrolled1 locationNCT05621070
Completed
Phase 3
Dose Response Study of a Complementary Medicine Formulation in Primary Hypercholesterolaemia
Primary Hypercholesterolaemia
Pathways40 enrolled1 locationACTRN12605000232639